(MedPage Today) — Ideally, the approval of a new drug should be exclusively the province of science, but for a more than half-trillion-dollar-a-year industry, it couldn’t possibly remain so. The same libertarian posture of the earlier twentieth…
Source link : https://www.medpagetoday.com/opinion/second-opinions/115722
Author :
Publish date : 2025-05-22 18:30:00
Copyright for syndicated content belongs to the linked Source.
